To determine whether EZH2/PRC2 components are deregulated in PTC and ATC, we first analyzed the expression of EZH2, EED and SUZ12 in BRAFV600E thyroid cancer cell lines (Figure 1A,B). This evidence concerns the gene EZH2 and thyroid gland carcinoma.